CF
ABBV icon

Corrigan Financial’s AbbVie ABBV Stock Holding History

Corrigan Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,680
Closed -$361K – 38
2023
Q2 		$361K Buy
2,680
+2
+0.1% +$293 0.11% 53
2023
Q1 		$427K Sell
2,678
-124
-4% -$19K 0.14% 45
2022
Q4 		$453K Buy
2,802
+3
+0.1% +$460 0.17% 43
2022
Q3 		$376K Buy
2,799
+4
+0.1% +$574 0.14% 49
2022
Q2 		$428K Sell
2,795
-998
-26% -$152K 0.16% 47
2022
Q1 		$615K Buy
3,793
+941
+33% +$137K 0.19% 41
2021
Q4 		$386K Sell
2,852
-184
-6% -$21.7K 0.11% 55
2021
Q3 		$327K Hold
3,036
– – 0.1% 58
2021
Q2 		$342K Sell
3,036
-175
-5% -$19.7K 0.1% 57
2021
Q1 		$348K Buy
3,211
+2
+0.1% +$214 0.12% 54
2020
Q4 		$344K Buy
3,209
+2
+0.1% +$192 0.15% 46
2020
Q3 		$281K Sell
3,207
-848
-21% -$79.8K 0.14% 47
2020
Q2 		$398K Buy
4,055
+2
+0% +$176 0.21% 33
2020
Q1 		$309K Sell
4,053
-1
-0% -$85 0.23% 38
2019
Q4 		$359K Buy
4,054
+5
+0.1% +$415 0.25% 36
2019
Q3 		$307K Buy
4,049
+3
+0.1% +$206 0.23% 38
2019
Q2 		$294K Sell
4,046
-598
-13% -$47K 0.22% 40
2019
Q1 		$374K Buy
4,644
+1,600
+53% +$131K 0.27% 37
2018
Q4 		$281K Buy
3,044
+2
+0.1% +$176 0.23% 34
2018
Q3 		$288K Sell
3,042
-390
-11% -$37K 0.21% 33
2018
Q2 		$318K Buy
3,432
+2
+0.1% +$195 0.24% 30
2018
Q1 		$325K Buy
3,430
+251
+8% +$27.6K 0.25% 28
2017
Q4 		$307K Sell
3,179
-22
-0.7% -$2.07K 0.26% 30
2017
Q3 		$284K Sell
3,201
-147
-4% -$11.2K 0.25% 35
2017
Q2 		$243K Buy
+3,348
New +$225K 0.23% 37

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Corrigan Financial's ABBV Position: Q3 2023 in Review

Corrigan Financial sold out of AbbVie (ABBV) in Q3 2023, closing a stake of 2,680 shares — an estimated $361K sold.

Corrigan Financial first reported a position in ABBV in Q2 2017 and held it in 25 quarters. The position peaked at $615K in Q1 2022. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

  • Corrigan Financial reported no remaining AbbVie position as of Q3 2023 after selling out during the quarter.
  • Corrigan Financial sold 2,680 AbbVie shares in Q3 2023, an estimated $361K.
  • Corrigan Financial first reported a position in AbbVie in Q2 2017 and held it in 25 quarters.
  • Corrigan Financial's AbbVie position peaked at $615K in Q1 2022.
  • 3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Corrigan Financial's 13F filing for Q3 2023, filed 16 Oct 2023.